Assenagon Asset Management S.A. raised its position in shares of Xylem Inc. (NYSE:XYL – Free Report) by 6.9% during the 1st quarter, Holdings Channel.com reports. The firm owned 295,610 shares of the industrial products company’s stock after purchasing an additional 19,114 shares during the period. Assenagon Asset Management S.A.’s holdings in Xylem were worth $35,325,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of XYL. Knuff & Co LLC purchased a new stake in shares of Xylem in the third quarter worth $27,000. Board of the Pension Protection Fund purchased a new position in shares of Xylem during the 4th quarter valued at $27,000. Commonwealth Retirement Investments LLC bought a new position in Xylem in the 4th quarter worth $27,000. Wexford Capital LP bought a new stake in Xylem during the third quarter valued at about $27,000. Finally, Ramirez Asset Management Inc. raised its holdings in shares of Xylem by 100.0% in the third quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock worth $30,000 after buying an additional 100 shares during the period. 87.96% of the stock is currently owned by institutional investors.
Xylem Price Performance
NYSE XYL opened at $116.60 on Friday. The company has a market cap of $27.71 billion, a PE ratio of 29.00, a P/E/G ratio of 1.66 and a beta of 1.04. The firm’s 50 day moving average price is $113.05 and its 200-day moving average price is $125.38. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27.
Xylem Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were given a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s payout ratio is presently 42.79%.
Wall Street Analyst Weigh In
A number of research firms recently issued reports on XYL. Weiss Ratings cut Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. Stifel Nicolaus reduced their target price on Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. Barclays lowered their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research note on Wednesday, April 29th. CLSA upgraded shares of Xylem to a “hold” rating in a report on Thursday. Finally, Oppenheimer reduced their price target on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 29th. Eight analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $153.54.
Check Out Our Latest Research Report on XYL
Insiders Place Their Bets
In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the transaction, the chief accounting officer owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jerome A. Peribere bought 1,210 shares of Xylem stock in a transaction on Monday, May 4th. The stock was purchased at an average price of $116.61 per share, with a total value of $141,098.10. Following the completion of the acquisition, the director directly owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This represents a 4.65% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.32% of the company’s stock.
About Xylem
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories
- Five stocks we like better than Xylem
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
